LogicBio Therapeutics, Inc. (LOGC) EPS Estimated At $-0.47; Evanston Investments Dba Evanston Advisors Has Boosted Reinsurance Group Of America (RGA) Holding By $329,904

Reinsurance Group of America, Incorporated (NYSE:RGA) Logo

Analysts expect LogicBio Therapeutics, Inc. (NASDAQ:LOGC) to report $-0.47 EPS on March, 4.After having $-4.03 EPS previously, LogicBio Therapeutics, Inc.’s analysts see -88.34% EPS growth. The stock decreased 2.63% or $0.25 during the last trading session, reaching $9.24. About 1,676 shares traded. LogicBio Therapeutics, Inc. (NASDAQ:LOGC) has 0.00% since February 13, 2018 and is . It has by 0.00% the S&P500.

Evanston Investments Inc Dba Evanston Advisors increased Reinsurance Group Of America Inc. (RGA) stake by 4.05% reported in 2018Q3 SEC filing. Evanston Investments Inc Dba Evanston Advisors acquired 2,291 shares as Reinsurance Group Of America Inc. (RGA)’s stock declined 1.90%. The Evanston Investments Inc Dba Evanston Advisors holds 58,873 shares with $8.51M value, up from 56,582 last quarter. Reinsurance Group Of America Inc. now has $8.97 billion valuation. The stock decreased 1.01% or $1.45 during the last trading session, reaching $142.79. About 181,464 shares traded. Reinsurance Group of America, Incorporated (NYSE:RGA) has declined 14.40% since February 13, 2018 and is downtrending. It has underperformed by 14.40% the S&P500. Some Historical RGA News: 23/04/2018 – DJ Reinsurance Group of America Incor, Inst Holders, 1Q 2018 (RGA); 28/03/2018 – CHINA REINSURANCE GROUP CORP – FY NET PREMIUM EARNED RMB98.28 BLN VS RMB82.62 BLN; 27/04/2018 – Consolidated Research: 2018 Summary Expectations for MGM Growth Properties, Reinsurance Group of America, Cincinnati Bell, GAIN; 28/03/2018 – CHINA REINSURANCE GROUP CORP – FY PROFIT ATTRIBUTABLE RMB5.26 BLN VS RMB5.15 BLN A YEAR AGO; 29/03/2018 – A.M. Best Affirms Credit Ratings of Insurance Subsidiaries of Nassau Reinsurance Group Holdings, L.P; 16/03/2018 – CHINA REINSURANCE GROUP CORP 1508.HK – 2-MTH AGGREGATE PREMIUMS INCOME AS DERIVED FROM CHINA CONTINENT PROPERTY & CASUALTY INSURANCE CO RMB7,050 MLN; 26/04/2018 – Reinsurance Group: 1Q ROE 21.1%; 18/05/2018 – CHINA REINSURANCE GROUP-PREMIUMS INCOME DERIVED FROM CHINA CONTINENT PROPERTY & CASUALTY INSURANCE CO LTD FROM JAN 2018-APRIL 2018 WAS RMB14,912 MLN; 28/03/2018 – CHINA REINSURANCE GROUP CORP 1508.HK – REGISTERED CAPITAL OF CHINA CONTINENT INSURANCE WILL BE CHANGED TO RMB15.12 BLN; 17/05/2018 – FITCH AFFIRMS RGA REINSURANCE IFS RATING AT ‘A’; OUTLOOK STABLE

Investors sentiment decreased to 0.76 in 2018 Q3. Its down 0.29, from 1.05 in 2018Q2. It is negative, as 32 investors sold RGA shares while 157 reduced holdings. 50 funds opened positions while 93 raised stakes. 56.00 million shares or 0.84% less from 56.48 million shares in 2018Q2 were reported. First Republic Invest Mngmt has invested 0% in Reinsurance Group of America, Incorporated (NYSE:RGA). Captrust Advsr, a North Carolina-based fund reported 953 shares. Great West Life Assurance Can invested in 0.02% or 62,372 shares. Jpmorgan Chase And has invested 0% in Reinsurance Group of America, Incorporated (NYSE:RGA). Regions Corp reported 0.02% of its portfolio in Reinsurance Group of America, Incorporated (NYSE:RGA). Dean Investment Associates Limited Liability Com has 0.11% invested in Reinsurance Group of America, Incorporated (NYSE:RGA). Hbk Invs Lp stated it has 20,248 shares. Metropolitan Life Ins Ny holds 0.05% in Reinsurance Group of America, Incorporated (NYSE:RGA) or 18,168 shares. Grantham Mayo Van Otterloo Limited Com stated it has 2,400 shares or 0% of all its holdings. Archford Strategies Llc reported 31 shares stake. California State Teachers Retirement owns 112,244 shares. Fulton Fincl Bank Na reported 1,459 shares. Merian Glob Investors (Uk) holds 0.01% of its portfolio in Reinsurance Group of America, Incorporated (NYSE:RGA) for 6,100 shares. State Teachers Retirement System, New York-based fund reported 103,877 shares. Alliancebernstein LP reported 1.50 million shares.

Since November 6, 2018, it had 2 insider purchases, and 5 selling transactions for $2.01 million activity. Another trade for 4,034 shares valued at $597,975 was sold by Manning Anna. LARSON TODD C also sold $672,199 worth of Reinsurance Group of America, Incorporated (NYSE:RGA) shares. 100 shares were bought by MATSON – TIMOTHY T, worth $13,053. Laughlin John P Jr sold 2,000 shares worth $296,265. Boot Arnoud W.A. sold $90,520 worth of stock or 620 shares.

Among 3 analysts covering Reinsurance Group (NYSE:RGA), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Reinsurance Group had 3 analyst reports since August 17, 2018 according to SRatingsIntel. The firm earned “Neutral” rating on Friday, August 17 by Credit Suisse. The firm has “Outperform” rating by RBC Capital Markets given on Tuesday, December 11. Morgan Stanley maintained the stock with “Underweight” rating in Tuesday, November 13 report.

More notable recent Reinsurance Group of America, Incorporated (NYSE:RGA) news were published by: Seekingalpha.com which released: “Reinsurance Group of America Q4 EPS falls short; new $400M buyback – Seeking Alpha” on January 28, 2019, also Businesswire.com with their article: “RGA Elects New Member to Board of Directors – Business Wire” published on January 25, 2019, Globenewswire.com published: “Research Report Identifies Whirlpool, Adtalem Global Education, Reinsurance Group of America, WR Berkley, Veracyte, and 22nd Century Group with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement – GlobeNewswire” on February 01, 2019. More interesting news about Reinsurance Group of America, Incorporated (NYSE:RGA) were released by: Benzinga.com and their article: “Earnings Scheduled For January 28, 2019 – Benzinga” published on January 28, 2019 as well as Seekingalpha.com‘s news article titled: “Reinsurance Group of America declares $0.60 dividend – Seeking Alpha” with publication date: January 28, 2019.

More notable recent LogicBio Therapeutics, Inc. (NASDAQ:LOGC) news were published by: Seekingalpha.com which released: “LogicBio Therapeutics prices IPO – Seeking Alpha” on October 19, 2018, also Seekingalpha.com with their article: “LogicBio Therapeutics readies IPO – Seeking Alpha” published on September 26, 2018, Nasdaq.com published: “Friday 10/26 Insider Buying Report: LOGC, CFG – Nasdaq” on October 26, 2018. More interesting news about LogicBio Therapeutics, Inc. (NASDAQ:LOGC) were released by: Globenewswire.com and their article: “LogicBio Therapeutics Announces Closing of Initial Public Offering – GlobeNewswire” published on October 23, 2018 as well as Globenewswire.com‘s news article titled: “LogicBio Therapeutics Announces Pricing of Initial Public Offering – GlobeNewswire” with publication date: October 18, 2018.

LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The company has market cap of $204.91 million. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect. It currently has negative earnings. The Company’s lead product candidate is LB-001 that is been developed for the treatment of Methylmalonic Acidemia, a life-threatening disease that presents at birth.

Reinsurance Group of America, Incorporated (NYSE:RGA) Institutional Positions Chart